Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: Clinical outcome up to five years from three centers

European Urology

Volumn 44, Issue 1, 2003, Pages 89-93

  Zlotta, Alexandre R ^a   Giannakopoulos, Xenofon ^b   Maehlum, Odd ^c   Ostrem, Tonnes ^c   Schulman, Claude C ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF IOANNINA   (Greece)

^c Haugesund Medical Center   (Norway)

Author keywords

BPH; Minimally invasive therapy; TUNA

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; COMORBIDITY; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MORTALITY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RESIDUAL URINE; RETREATMENT; SCORING SYSTEM; SYMPTOM; TECHNIQUE; TRANSURETHRAL NEEDLE ABLATION; TREATMENT FAILURE; TREATMENT OUTCOME; URINE FLOW RATE;

EID: 0038311866     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00218-5     Document Type: Article

References (18)

1. Schulman CC, Zlotta AR. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia. In Resnick MI, Thompson IA, editors. Advanced therapy of prostate disease. London: B.C. Decker Inc.; 2000. p. 552-61.
2. Zlotta AR, Raviv G, Peny M-O, Noël J-C, Haot J, Schulman CC. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. J Urol 1997;157:894-9.
3. Naslund MJ. Transurethral needle ablation of the prostate. Urol 1997;50:167-72.
4. Issa MM, Stein B, Benson R, Knoll LD, Fay R. Prospective multicenter study of transperincal prostatic block for transurethral needle ablation of the prostate. Urology 2000;56:1052-5.
5. Issa MM, Perez-Brayfield M, Petros JA, Anastasia K, Labadia AJ, Miller LE. A prospective study of transperineal prostatic block for transurethral needle ablation for benign prostatic hyperplasia: the Emory University Experience. J Urol 1999;162:1636-9.
6. Bruskewitz R, Issa MM, Roehrborn CG, Naslund MJ, Perez-Marrero R, Shumaker BP, et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998;159:1588-94.
7. Roehrborn CG, Issa MM, Bruskewitz RC, Naslund MJ, Oesterling JE, Perez-Marrero R, et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology 1998;51:415-21.
8. Murai M, Tachibana M, Miki M, Shiozawa H, Hirao Y, Okajima E. Transurethral needle ablation of the prostate: an initial Japanese clinical trial. Int J Urol 2001;8:99-105.
9. Roehrborn CG, Burkhard FC, Bruskewitz RC, Issa MM, Perez-Marrero R, Naslund MJ, et al. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. J Urol 1999;162:92-7.
10. Campo B, Bergamaschi F, Corrada P, Ordesi G. Transurethral needle ablation (TUNA) of the prostate: a clinical and urodynamic evaluation. Urol 1997;49:847-50.
11. Schulman CC, Zlotta AR. Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience. Urology 1995;45:28-33.
12. Zlotta AR, Djavan B. Minimally invasive therapies for benign prostatic hyperplasia in the new millennium: long-term data. Curr Opin Urol 2002;12:7-14.
13. Schulman CC, Lock TM, Buzelin JM, Boeminghaus F, Stephenson TP, Talja M; European Tamsulosin Study Group. Long-term use of tamsulosin to treat lower urinary tract syiiiptoms/benign prostatic hyperplasia. J Urol 2001;166:1358-63.
14. Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de La Rosette JJ. Long-term follow-up of randomized transurethral microwave thennotherapy versus transurethral prostatic resection study. J Urol 2001;165:1533-8.
15. Djavan B, Seitz C, Roehrborn CG, Remzi M, Fakhari M, Waldert M, et al. Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology 2001;57:66-70.
16. Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 1997;79:181-5.
17. Floratos DL, Soncke GS, Francisca EA, Kiemeney LA, Debruyne FM, de la Rosette JJ. Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction. Urology 2000;56:604-9.
18. Sullivan LD, Paterson RF, Gleave ME, Goldenberg SL, McLoughlin MG, Heaton JP. Early experience with transurethral needle ablation of large prostates. Can J Urol 1999;6:686-91.